Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 3
2012 10
2013 6
2014 8
2015 6
2016 1
2017 1
2020 1
2022 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Related Articles by Review for PMID: 31644194

35 results

Results by year

Filters applied: . Clear all
Page 1
Protease Inhibitors (HCV).
[No authors listed] [No authors listed] 2022 Jan 25. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2022 Jan 25. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31644194 Free Books & Documents. Review.
Hepatitis C (HCV) Agents.
[No authors listed] [No authors listed] 2022 Feb 7. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2022 Feb 7. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31644192 Free Books & Documents. Review.
Direct anti-HCV agents.
Zhang X. Zhang X. Acta Pharm Sin B. 2016 Jan;6(1):26-31. doi: 10.1016/j.apsb.2015.09.008. Epub 2015 Nov 24. Acta Pharm Sin B. 2016. PMID: 26904396 Free PMC article. Review.
Faldaprevir for the treatment of hepatitis C.
Kanda T, Yokosuka O, Omata M. Kanda T, et al. Int J Mol Sci. 2015 Mar 4;16(3):4985-96. doi: 10.3390/ijms16034985. Int J Mol Sci. 2015. PMID: 25749475 Free PMC article. Review.
Emerging therapies for hepatitis C.
Kim DY, Ahn SH, Han KH. Kim DY, et al. Gut Liver. 2014 Sep;8(5):471-9. doi: 10.5009/gnl14083. Epub 2014 Aug 18. Gut Liver. 2014. PMID: 25228970 Free PMC article. Review.
[Direct antiviral treatment strategies in chronic hepatitis C].
Neumann-Haefelin C, Blum HE, Thimme R. Neumann-Haefelin C, et al. Dtsch Med Wochenschr. 2012 Jun;137(25-26):1360-5. doi: 10.1055/s-0032-1305064. Epub 2012 May 31. Dtsch Med Wochenschr. 2012. PMID: 22653493 Review. German.
Hepatitis C virus NS5A inhibitors and drug resistance mutations.
Nakamoto S, Kanda T, Wu S, Shirasawa H, Yokosuka O. Nakamoto S, et al. World J Gastroenterol. 2014 Mar 21;20(11):2902-12. doi: 10.3748/wjg.v20.i11.2902. World J Gastroenterol. 2014. PMID: 24659881 Free PMC article. Review.
35 results